Lancet warns of new biosecurity risks

A new editorial in The Lancet, published on August 29, 2026, warns that political obsession with the origins of COVID-19 is obstructing critical discussions on emerging biosecurity risks. The piece states that rapid advances in artificial intelligence and biotechnology are reshaping global threats and demand urgent political attention.

The editorial identifies five key areas of concern. It argues that a backward-looking focus on conspiracy theories, exemplified by recent US Senate hearings involving retired NIAID director Anthony Fauci, makes balanced debate difficult.

AI and synthetic biology advances

First, the editorial highlights major progress in AI-enabled biological design. It cites a study published earlier in August 2026 in the journal Science, which reported the first synthesis of a complete functional viral genome designed by generative AI. The AI-designed bacteriophages could overcome resistant strains of E. coli. While this milestone holds substantial medical potential, experts warn that safeguards are needed to understand and minimize biosecurity risks.

Oversight and dual-use research

Second, the piece questions how to implement effective oversight of DNA synthesis to stop malicious actors from constructing harmful pathogens. It notes an unresolved debate over whether screening should be a voluntary, industry-led effort or legally mandated across all providers and countries.

Third, it points to a renewed debate around governing dual-use research. This refers to well-intentioned research that could also be misused for harm. The editorial mentions a US policy from July 2026 that ended federally funded gain-of-function research and placed restrictions on international work. The policy has received a mixed response. The Lancet argues that while aiming to strengthen biosecurity, prohibiting such research may impede the ability to address infectious disease threats. It also states that a ban does not stop research elsewhere and that regulatory machinery to enact the policy is lacking.

Mirror life and lab proliferation

Fourth, the editorial raises the risks of developing 'mirror life'. This refers to a hypothetical form of artificial life constructed from synthetic biomolecules of reverse chirality. A 2024 Science article warned that such mirror bacteria could potentially evade the immune systems of humans, animals, and plants, causing fatal infections. International bodies have issued statements of concern, and the debate now centres on where to draw red lines for this research.

Fifth, the piece addresses the proliferation of high-containment biosafety level 4 (BSL-4) laboratories. Citing the Global BioLabs Report 2023, it notes the number of BSL-4 labs has more than doubled over a decade. There are now 69 such facilities across 27 countries, alongside increasing numbers of BSL-3 labs. The editorial states that while many countries with these labs score high on biosafety governance, fewer do so on biosecurity governance. Only one scores high on dual-use research governance. It concludes that the post-COVID-19 expansion of high-security laboratories has not been matched by adequate bio-risk management policies.

The editorial concludes that scientists must have a central role in governance discussions due to the technical nature of the questions. However, it states that effective governance must also find a way to involve broader societal engagement, noting that public trust in scientists has eroded. Safely navigating this era requires forging a new social contract where the public are active partners, not passive subjects.